Borrelia burgdorferi was discovered to be the cause of Lyme disease in 1983, leading to seroassays. The 1994 serodiagnostic testing guidelines predated a full understanding of key B. burgdorferi antigens and have a number of shortcomings. These serologic tests cannot distinguish active infection, past infection, or reinfection. Reliable direct-detection methods for active B. burgdorferi infection have been lacking in the past but are needed and appear achievable. New approaches have effectively been applied to other emerging infections and show promise in direct detection of B. burgdorferi infections.
**Comment**Key quote:  “These serologic tests cannot distinguish active infection, past infection, or reinfection.”

In plain English, these tests don’t show squat.

Yet, my friends, these very useless tests have been used from the beginning to deny treatment to extremely sick people.  “It’s all in your head.  Here’s a anti-depressant.”  “Go, and be well.”  

Lyme patients and the doctors who dare treat them have been shouting this for decades, so the reason for this admission, and it is an admission, is that something’s in the pipeline that they think is going to appease us, and in fact, right after this post, I’m going to post another article that in fact gives the details on this “New direct detection” test.

 The only problem is, direct detection is nothing new.

Dr. Sin Hang Lee has sued the CDC over their suppression of HIS direct detection test.

Another great article showing how they’ve worked tirelessly to suppress direct detection tests:

Rewind time a little more and you will learn that Lida Mattman with her collegue JoAnne Whittacker did groundbreaking work on Lyme testing. Their Gold Standard Culture Method has disappeared thanks to the concerted suppression on microscopy.

According to Dr. Shaller, Bowen Research & Training Institute, Inc., is conducting ongoing research using the Bowen Q-RIBb (Quantitative Rapid Identification of Borrelia burgdorferi) test developed by Dr. JoAnne Whitaker. Due to lack of funding, the institute went from a CLIA lab to a research facility.

Bowen research has found the Bb antigen in whole blood, breast milk, urine, placental tissue, semen, eye fluid, teeth, foot nodules, shoulder fluid, spinal fluid, finger joint fluid, and African dust. Findings are documented with digital photography using Darkfield microscopy. The Bowen Lab receives blood specimens for Borrelia burgdorferi (Bb) from forty-six states, including Alaska and Hawaii. In addition, the Bowen lab receives blood from doctors ordering the test from Canada, Brazil, Denmark, Scotland, The Netherlands, Ireland, England, France, Spain, Germany, Switzerland, and the Canary Islands. The recent database numbers for those tested is approximately 6,000. According to a recent poll of patients clinically diagnosed with Lyme disease whose physicians had ordered the Bowen Q-RIBb test, 100% of those patients tested with the Bowen reported their tests were positive for Bb.

Here’s the thing, though, testing is NOT the end all with Lyme/MSIDS. Not even THIS new test.  If anyone is expecting the perfect test, to my knowledge none exists due to all the variables at play including but not limited to how long you’ve been infected and what other pathogens are at play.  The best approach at this point is STILL to go to a knowledgable, educated, experienced practitioner who understands this beast clinically and can diagnose and treat CLINICALLY.


Nothing about this beast is easy or straight forward.  Frankly, it doesn’t fit into the Western Medicine paradigm and it never will.  My first appointment with a LLMD was 90 minutes.  90 MINUTES!  Prior to that appointment I filled out a veritable encyclopedia’s worth of medical history dating back to infancy!  Since you can contract Lyme and numerous coinfections congenitally, it very well may be the reason for many peoples’ ill health that they’ve coped with for decades thinking it 1,000 different things.

No, this will never fit into a 10 minute Western Medicine paradigm.
%d bloggers like this: